“Effects of galcanezumab on acute medication use and health care resource utilization in treatment-resistant migraine: results from randomized, double blind, placebo-controlled clinical trial, conquer”, Headache Med, vol. 11, no. Supplement, p. 27, Nov. 2020, doi: 10.48208/HeadacheMed.2020.Supplement.27.